Clinical Trials Directory

Trials / Completed

CompletedNCT01078103

Corneal Endothelial Changes Associated With Phacoemulsification in Diabetes Mellitus Type II

Corneal Endothelial Changes Associated With Phacoemulsification in Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Frederiksberg University Hospital · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Some studies indicated that the diabetic corneal endothelium is morphologically abnormal and may be at risk in any intraocular surgical procedure, while others showed no significant differences between diabetic and non-diabetic corneal endothelium.The purpose of this study is to investigate the differences in corneal endothelial cell density and morphology in diabetic patients and normal patients after phacoemulsification with intraocular lens implantation.To investigate if haemoglobin A1c can be used as a predictor of corneal endothelial cell changes after phacoemulsification.

Detailed description

Some studies indicated that the diabetic corneal endothelium is morphologically abnormal and may be at risk in any intraocular surgical procedure, while others showed no significant differences between diabetic and non-diabetic corneal endothelium.The purpose of this study is to investigate the differences in corneal endothelial cell density and morphology in diabetic patients and normal patients after phacoemulsification with intraocular lens implantation.To investigate if haemoglobin A1c can be used as a predictor of corneal endothelial cell changes after phacoemulsification. Specular microscopy photos will be taken pre-. and 3 month postoperatively. Cellular parameters will be compared between the two groups prior and post surgery. Clinical significant difference is defined as 1 SD (300 cell/mm2)

Conditions

Timeline

Start date
2005-07-01
Primary completion
2008-04-01
Completion
2008-04-01
First posted
2010-03-02
Last updated
2010-03-02

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01078103. Inclusion in this directory is not an endorsement.